ONCOPRO LUNG BASIC PANEL Test
At DNA Labs UAE, we offer the ONCOPRO LUNG BASIC PANEL Test, a diagnostic test designed to detect genetic mutations in lung cancer patients. This comprehensive panel includes the analysis of several genes known to be frequently mutated in lung cancer, including EGFR, KRAS, ALK, and ROS1.
Test Cost: AED 2810.0
The ONCOPRO LUNG BASIC PANEL Test is priced at AED 2810.0.
Symptoms and Diagnosis
If you are experiencing symptoms of lung cancer or have already been diagnosed with the disease, the ONCOPRO LUNG BASIC PANEL Test can provide valuable insights into your genetic profile. By analyzing the DNA from your tumor sample, this test can identify specific mutations or alterations in the genes mentioned above, which may be driving the growth and spread of your cancer.
Test Components
- Alk1-FISH
- ROS1-FISH
- EGFR Mutation analysis
Sample Condition and Submission
To perform the ONCOPRO LUNG BASIC PANEL Test, we require a formalin-fixed paraffin-embedded tissue block. The sample should be shipped at room temperature and must contain at least 10% tumor cells. Additionally, a duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory for the test.
Report Delivery
Once the sample is received, the report will be delivered on the following schedule:
- Sample submitted on Monday or Thursday by 9 am – Report delivered on Friday
- Sample submitted on Friday or Tuesday – Report delivered on Tuesday
Method and Test Type
The ONCOPRO LUNG BASIC PANEL Test utilizes FISH (Fluorescence In Situ Hybridization) and Sanger Sequencing methods for analysis. This test falls under the category of cancer diagnostics and is conducted by our experienced team of oncologists in our CYTOGENETICS department.
Pre Test Information
It is important to ensure that the paraffin block used for the test contains at least 10% tumor cells. Additionally, the duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory for the test.
Personalized Treatment Options
The results of the ONCOPRO LUNG BASIC PANEL Test can provide crucial information for determining the most appropriate treatment options for lung cancer patients. By identifying specific mutations or alterations in the analyzed genes, our team of oncologists can recommend targeted therapies or immunotherapies that specifically target these mutations. This personalized approach to treatment can greatly improve patient outcomes.
It is important to note that the ONCOPRO LUNG BASIC PANEL Test is not a screening test for lung cancer. It is specifically designed for patients who have already been diagnosed with the disease and are seeking personalized treatment options based on their genetic profile.
| Test Name | ONCOPRO LUNG BASIC PANEL Test |
|---|---|
| Components | *Alk1-FISH*ROS1-FISH*EGFR Mutation analysis |
| Price | 2810.0 AED |
| Sample Condition | Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Paraffin block must contain 10% tumor cells. Duly filled Chromosome & FISH analysis Requisition Form(Form 17) is mandatory. |
| Report Delivery | Sample Mon / Thu by 9 am; Report Fri / Tue |
| Method | FISH, Sanger Sequencing |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | CYTOGENETICS |
| Pre Test Information | Paraffin block must contain 10% tumor cells. Duly filled Chromosome & FISH analysis Requisition Form(Form 17) is mandatory. |
| Test Details | The ONCOPRO Lung Basic Panel test is a diagnostic test used to detect genetic mutations in lung cancer patients. This panel includes the analysis of several genes that are known to be frequently mutated in lung cancer, such as EGFR, KRAS, ALK, and ROS1. By analyzing the DNA from a patient’s tumor sample, the ONCOPRO Lung Basic Panel test can identify specific mutations or alterations in these genes that may be driving the growth and spread of the cancer. This information is important for determining the most appropriate treatment options for the patient. The test is typically performed on a tumor biopsy sample or a liquid biopsy, which is a blood sample that contains circulating tumor DNA. The results of the test can help guide treatment decisions, such as the use of targeted therapies or immunotherapies that specifically target the identified mutations. It is important to note that the ONCOPRO Lung Basic Panel test is not a screening test for lung cancer. It is specifically designed for patients who have already been diagnosed with lung cancer and are seeking personalized treatment options based on their genetic profile. |
